Levine Mitchell S 4
4 · OncoCyte Corp · Filed Sep 12, 2019
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2019-09-12$2.01/sh+10,000$20,060→ 10,000 total
Footnotes (1)
- [F1]The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.